Trial Profile
A phase III, Three-arm trial of Apricitabine in Patients with HIV
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 29 Mar 2017
Price :
$35
*
At a glance
- Drugs Apricitabine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Novita Healthcare
- 20 May 2015 New trial record